Literature DB >> 12806214

Mechanisms of skeletal muscle depletion in wasting syndromes: role of ATP-ubiquitin-dependent proteolysis.

Paola Costelli1, Francesco M Baccino.   

Abstract

PURPOSE OF REVIEW: Muscle protein wasting frequently complicates patient outcome in several chronic pathologies. The underlying mechanisms remain largely obscure, although studies on experimental models have clarified that a complex interplay of different factors such as nutrient supply, classical hormones, cytokines and other less well defined factors likely concur in causing muscle depletion. The aim of the present review is to highlight some crucial points in the interpretation of the data available about the contribution of the different proteolytic systems, with particular reference to the ubiquitin-proteasome system, in the onset of muscle protein wasting in disease states. RECENT
FINDINGS: Much effort has been directed to understanding the role of different signals, transduction pathways, and proteolytic mechanisms in the acceleration of muscle protein catabolism. Several reports propose that ATP-ubiquitin-dependent proteolysis plays a critical role in the enhancement of muscle protein catabolism observed in different pathological states. Other papers, however, suggest that the lysosomal or the calcium-dependent proteolytic pathways or both may be involved. Finally, the studies have been extended to evaluate the possibility of interfering pharmacologically with the onset of muscle protein hypercatabolism.
SUMMARY: As the present overview points out, several questions still remain unanswered in the issue of muscle wasting. While many different signals that have the potential to enforce the acceleration of muscle protein breakdown have been identified, it is largely unknown how they are transduced and converge into the hypercatabolic response and how the proteolytic pathways involved are activated. The concept seems to emerge that there may be a coordinated action of different proteolytic pathways in setting up muscle protein turnover towards excess catabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12806214     DOI: 10.1097/01.mco.0000078984.18774.02

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  16 in total

Review 1.  Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?

Authors:  Maurizio Muscaritoli; Simone Lucia; Alessio Molfino; Tommy Cederholm; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2012-07-08       Impact factor: 3.397

2.  Cachexia worsens prognosis in patients with resectable pancreatic cancer.

Authors:  Jeannine Bachmann; Mathias Heiligensetzer; Holger Krakowski-Roosen; Markus W Büchler; Helmut Friess; Marc E Martignoni
Journal:  J Gastrointest Surg       Date:  2008-03-18       Impact factor: 3.452

Review 3.  Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review.

Authors:  William Paul Skelton; Hiral Parekh; Jason S Starr; Jose Trevino; Jessica Cioffi; Steven Hughes; Thomas J George
Journal:  J Gastrointest Cancer       Date:  2018-03

4.  Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy.

Authors:  Sarah M Senf; Stephen L Dodd; Joseph M McClung; Andrew R Judge
Journal:  FASEB J       Date:  2008-07-21       Impact factor: 5.191

5.  IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS.

Authors:  Angélique Heckmann; Caroline Waltzinger; Paul Jolicoeur; Michel Dreano; Marie H Kosco-Vilbois; Yves Sagot
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

6.  Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance.

Authors:  Sílvia Busquets; Míriam Toledo; Marcel Orpí; David Massa; Maria Porta; Eva Capdevila; Núria Padilla; Valentina Frailis; Francisco J López-Soriano; H Q Han; Josep M Argilés
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-11-08       Impact factor: 12.910

7.  Nutritional screening and early treatment of malnutrition in cancer patients.

Authors:  Lidia Santarpia; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-02-22       Impact factor: 12.910

8.  Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.

Authors:  Jeannine Bachmann; Knut Ketterer; Christiane Marsch; Kerstin Fechtner; Holger Krakowski-Roosen; Markus W Büchler; Helmut Friess; Marc E Martignoni
Journal:  BMC Cancer       Date:  2009-07-28       Impact factor: 4.430

9.  Cancer cachexia: impact, mechanisms and emerging treatments.

Authors:  Vanessa C Vaughan; Peter Martin; Paul A Lewandowski
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-10-25       Impact factor: 12.910

Review 10.  Role of Inflammation in Muscle Homeostasis and Myogenesis.

Authors:  Domiziana Costamagna; Paola Costelli; Maurilio Sampaolesi; Fabio Penna
Journal:  Mediators Inflamm       Date:  2015-10-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.